The Transcription Factor NGFI-B (Nur77) and Retinoids Play a Critical Role in Acute Neuroleptic-Induced Extrapyramidal Effect and Striatal Neuropeptide Gene Expression

Neuropsychopharmacology

Volumn 29, Issue 2, 2004, Pages 335-346

  Éthier, Isabelle ^a   Beaudry, Geneviève ^a   St Hilaire, Michel ^a   Milbrandt, Jeff ^b   Rouillard, Claude ^a,c   Lévesque, Daniel ^a,c  

^a LAVAL UNIVERSITY   (Canada)

^b WASHINGTON UNIVERSITY   (United States)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

Antipsychotic drugs; Dopamine D2 receptors; Extrapyramidal symptoms; Immediate early genes; Ligand activated transcription factors; NR4AI

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALITRETINOIN; DOCOSAHEXAENOIC ACID; DOPAMINE RECEPTOR BLOCKING AGENT; DYNORPHIN; ENKEPHALIN; HALOPERIDOL; IMMEDIATE EARLY PROTEIN; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR INDUCIBLE PROTEIN B; NEUROLEPTIC AGENT; NEUROPEPTIDE; NEUROTENSIN; PROTEIN C FOS; PROTEIN NOR 1; PROTEIN NURR7; RACLOPRIDE; RETINOID X RECEPTOR GAMMA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATALEPSY; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG EFFECT; EXTRAPYRAMIDAL SYMPTOM; GENE EXPRESSION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIPSYCHOTIC AGENTS; AUTORADIOGRAPHY; BASAL GANGLIA DISEASES; BEHAVIOR, ANIMAL; BINDING SITES; CATALEPSY; CORPUS STRIATUM; DNA-BINDING PROTEINS; DOCOSAHEXAENOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG INTERACTIONS; GENE EXPRESSION REGULATION; HALOPERIDOL; IN SITU HYBRIDIZATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROPEPTIDES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, RETINOIC ACID; RECEPTORS, STEROID; RETINOID X RECEPTORS; RETINOIDS; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION FACTORS; TRETINOIN;

EID: 0842264891     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300318     Document Type: Article

References (52)

1. Allison DB, Casey DE (2001). Antipsychotic-induced weight gain: a review of the literature. J Clin Psychiatry 62(Suppl 7): 22-31.
2. Augood SJ, Westmore K, Emson PC (1997). Phenotypic characterization of neurotensin messenger RNA-expressing cells in the neuroleptic-treated rat striatum: a detailed cellular co-expression study. Neuroscience 76: 763-774.
3. Beaudry G, Langlois M-C, Weppe I, Rouillard C, Lévesque D (2000). Contrasting patterns and cellular specificity of transcriptional regulation of the nuclear receptor nerve growth factor-inducible B by haloperidol and clozapine in the rat forebrain. J Neurochem 75: 1694-1702.
4. Castillo SO, Xiao Q, Kostrouch Z, Dozin B, Nikodem VM (1998). A divergent role of COOH-terminal domains in Nurr1 and Nur77 transactivation. Gene Exp 7: 1-12.
5. Chambon P (1996). A decade of molecular biology of retinoic acid receptors. FASEB J 10: 940-954.
6. Chan RM, Stewart MJ, Crabb DW (1997). A direct repeat (DR-1) element in the first exon modulates transcription of the preproenkephalin A gene. Brain Res Mol Brain Res 45: 50-58.
7. Cheng LE, Chan FK, Cado D, Winoto A (1997). Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis. EMBO J 16: 1865-1875.
8. Crawford PA, Sadovsky Y, Woodson K, Lee SL, Milbrandt J (1995). Adrenocortical function and regulation of the steroid 21-hydroxylase gene in NGFI-B-deficient mice. Mol Cell Biol 15: 4331-4336.
9. Dawson MI, Hobbs PD, Peterson VJ, Leid M, Lange CW, Feng K-C et al (2001). Apoptosis induction in cancer cells by a novel analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene-carboxylic acid lacking retinoid receptor transcriptional activation activity. Cancer Res 61: 4723-4730.
10. de Urquiza AM, Liu S, Sjöberg M, Zetterström RH, Griffiths W, Sjövall J et al (2000). Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 290: 2140-2144.
11. Dobner PR, Fadel J, Deitemeyer N, Carraway RE, Deutch AY (2001). Neurotensin-deficient mice show altered responses to antipsychotic drugs. Proc Natl Acad Sci USA 98: 8048-8053.
12. Egea PF, Mitschler A, Moras D (2002). Molecular recognition of agonist ligands by RXRs. Mol Endocrinol 16: 987-997.
13. 1 and D dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250: 1429-1432.
14. Gervais J, Soghomonian J-J, Richard D, Rouillard C (1999). Dopamine and serotonin interactions in the modulation of the expression of the immediate-early transcription factor, nerve growth factor-inducible B, in the striatum. Neuroscience 91: 1045-1054.
15. Goodman AB (1998). Three independent lines of evidence suggest retinoids as causal to schizophrenia. Proc Natl Acad Sci USA 95: 7240-7244.
16. Hazel TG, Nathans D, Lau LF (1988). A gene inducible by serum growth factors encodes a member of the steroid and thyroid hormone receptor superfamily. Proc Natl Acad Sci USA 85: 8444-8448.
17. Herdegen T, Leah JD (1998). Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res Brain Res Rev 28: 370-490.
18. 3-calcineurin-signaling cascade. J Neurosci 20: 8987-8995.
19. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM et al (1992). 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68: 397-406.
20. Hiroi N, Graybiel AM (1996). Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum. J Comp Neurol 374: 70-83.
21. Hoffman DC, Donovan H (1995). Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability. Psychopharmacology (Berl) 120: 128-133.
22. Kane JM (2001). Extrapyramidal side effects are unacceptable. Eur Neuropsychopharmacol 11: S397-S403.
23. Kovalovsky D, Refojo D, Liberman AC, Hochbaum D, Paez-Pereda M, Coso OA et al (2002). Activation and induction of NUR77/ NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways. Mol Endocrinol 16: 1638-1651.
24. Krezel W, Ghyselinck N, Samad TA, Dupé V, Kastner P, Borrelli E et al (1998). Impaired locomotion and dopamine signaling in retinoid receptor mutant mice. Science 279: 863-867.
25. Krezel W, Kastner P, Chambon P (1999). Differential expression of retinoid receptors in the adult mouse central nervous system. Neuroscience 89: 1291-1300.
26. LaMantia A-S (1999). Forebrain induction, retinoic acid, and vulnerability to schizophrenia: insights from molecular and genetic analysis in developing mice. Biol Psychiatry 46: 19-30.
27. Langlois M-C, Beaudry G, Zekki H, Rouillard C, Lévesque D (2001). Impact of antipsychotic drug administration on the expression of nuclear receptors in the neocortex and striatum of the rat brain. Neuroscience 106: 117-128.
28. 2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J Comp Neurol 355: 418-426.
29. Lee SL, Wesselschmidt RL, Linette GP, Kanagawa O, Russell JH, Milbrandt J (1995). Unimpaired thymic and peripheral T cell death in mice lacking the nuclear receptor NGFI-B (Nur77). Science 269: 532-535.
30. Leveque J-C, Macias W, Rajadhyaksha A, Carlson RR, Barczak A, Kang S et al (2000). Intracellular modulation of NMDA receptor function by antipsychotic drugs. J Neurosci 20: 4011-4020.
31. 2 receptors. Psychopharmacology (Berl) 112: S40-S54.
32. Liu Z-G, Smith SW, McLaughlin KA, Schwartz LM, Osborne BA (1994). Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene Nur77. Nature 367: 281-284.
33. Maden M (2002). Retinoid signalling in the development of the central nervous system. Nat Rev Neurosci 3: 843-853.
34. Maira M, Martens C, Batsché E, Gauthier Y, Drouin J (2003). Dimer-specific potentiation of NGFI-B (Nur77) transcriptional activity by the protein kinase A pathway and AF-1-dependent coactivator recruitment. Mol Cell Biol 23: 763-776.
35. Maltais A, Labelle Y (2000). Structure and expression of the mouse gene encoding the orphan nuclear receptor TEC. DNA Cell Biol 19: 121-130.
36. Meltzer HY (1995). Atypical antipsychotic drugs. In: Bloom FE, Kupfer DJ (eds). Psychopharmacology: The Fourth Generation of Progress. Raven Press: New York, pp 1277-1286.
37. Milbrandt J (1988). Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene. Neuron 1: 183-188.
38. Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G et al (2001). Mechanisms of estrogen action. Physiol Rev 81: 1535-1565.
39. Paulsen RF, Granas K, Johnsen H, Rolseth V, Sterri S (1995). Three related brain nuclear receptors, NGFI-B, Nurr1, and NOR-1, as transcriptional activators. J Mol Neurosci 6: 249-255.
40. Perlmann T, Jansson L (1995). A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes Dev 9: 769-782.
41. Saga Y, Kobayashi M, Ohta H, Murai N, Nakai N, Oshima M et al (1999). Impaired extrapyramidal function caused by the targeted disruption of retinoid X receptor RXRγ1 isoform. Genes Cells 4: 219-228.
42. Seeman P (1995). Dopamine receptors: clinical correlates. In: Bloom FE, Kupfer DJ (eds). Psychopharmacology: The Fourth Generation of Progress. Raven Press: New York, pp 295-302.
43. Slagsvold HH, Ostvold A-C, Fallgren AB, Paulsen RE (2002). Nuclear receptor and apoptosis initiator NGFI-B is a substrate for kinase ERK2. Biochem Biophys Res Commun 291: 1146-1150.
44. Steiner H, Gerfen CR (1998). Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp Brain Res 123: 60-76.
45. 3 receptor antisense administration reduces basal c-fos and NGFI-B mRNA levels in the rat forebrain. Synapse 32: 51-57.
46. Vivat V, Zechel C, Wurtz J-M, Bourguet W, Kagechika H, Umemiya H et al (1997). A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers. EMBO J 16: 5697-5709.
47. Wagner E, Luo T, Dräger UC (2002). Retinoic acid synthesis in the postnatal mouse brain marks distinct developmental stages and functional systems. Cereb Cortex 12: 1244-1253.
48. Wansa KD, Harris JM, Muscat GE (2002). The activation function-1 domain of Nur77/NR4A1 mediates trans-activation, cell specificity, and coactivator recruitment. J Biol Chem 277: 33001-33011.
49. Werme M, Ringholm A, Olson L, Brené S (2000). Differential patterns of induction of NGFI-B, Nor-1 and c-fos mRNAs in striatal subregions by haloperidol and clozapine. Brain Res 863: 112-119.
50. Woronicz JD, Calnan B, Ngo V, Winoto A (1994). Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature 367: 277-281.
51. Zetterström RH, Lindqvist E, de Urquiza AM, Tomac A, Eriksson U, Perlmann T et al (1999). Role of retinoids in the CNS: differential expression of retinoid binding proteins and receptors and evidence for presence of retinoic acid. Eur J Neurosci 11: 407-416.
52. Zetterström RH, Solomin L, Mitsiadis T, Olson L, Perlmann T (1996). Retinoid X receptor heterodimerization and developmental expression distinguish the orphan nuclear receptors NGFI-B, Nurr1, and Nor1. Mol Endocrinol 10: 1656-1666.